391 related articles for article (PubMed ID: 10785491)
21. Lethal endometrial recurrence after cone biopsy for microinvasive cervical adenocarcinoma.
Singh P; Scurry J; Proietto A
J Obstet Gynaecol Res; 2008 Jun; 34(3):413-7. PubMed ID: 18588617
[TBL] [Abstract][Full Text] [Related]
22. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
Blythe JG; Michael H; Hodel KA
J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
[TBL] [Abstract][Full Text] [Related]
23. [Management of in situ cervical adenocarcinoma].
Graesslin O; Dedecker F; Collinet P; Jouve E; Urbaniack D; Leroy JL; Boulanger JC; Quéreux C
Gynecol Obstet Fertil; 2006 Dec; 34(12):1178-84. PubMed ID: 17097907
[TBL] [Abstract][Full Text] [Related]
24. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
Goldstein NS; Mani A
Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
[TBL] [Abstract][Full Text] [Related]
25. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
[TBL] [Abstract][Full Text] [Related]
26. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
Salani R; Puri I; Bristow RE
Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
[TBL] [Abstract][Full Text] [Related]
29. [The optimal treatment of carcinoma in situ of the uterine cervix (author's transl)].
Majewski A; Börner P; Heidenreich W; Mestwerdt W; Spilker R
Geburtshilfe Frauenheilkd; 1977 Mar; 37(3):198-206. PubMed ID: 870382
[TBL] [Abstract][Full Text] [Related]
30. Invasive adenocarcinoma of the cervix following Lletz for adenocarcinoma in situ.
Townsend DE
Gynecol Oncol; 1996 Feb; 60(2):332. PubMed ID: 8631562
[No Abstract] [Full Text] [Related]
31. Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Poynor EA; Marshall D; Sonoda Y; Slomovitz BM; Barakat RR; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):960-5. PubMed ID: 16860853
[TBL] [Abstract][Full Text] [Related]
32. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
Schorge JO; Lea JS; Ashfaq R
J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
[TBL] [Abstract][Full Text] [Related]
33. [Value of conization in the therapy of carcinoma in situ].
Herzog RE
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):247-50. PubMed ID: 4007461
[TBL] [Abstract][Full Text] [Related]
34. Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
Im DD; Duska LR; Rosenshein NB
Gynecol Oncol; 1995 Nov; 59(2):179-82. PubMed ID: 7590468
[TBL] [Abstract][Full Text] [Related]
35. [Cervical pathology: significance and therapeutic impact of margin status].
Michy T; Leveque J; Loussouarn D; Dravet F; Dejode M; Sagan C; Descamps P; Classe JM
Bull Cancer; 2008 Dec; 95(12):1171-5. PubMed ID: 19091650
[TBL] [Abstract][Full Text] [Related]
36. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
Dedecker F; Graesslin O; Bonneau S; Quéreux C
Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
[TBL] [Abstract][Full Text] [Related]
37. [Conisation in stage Ia cervix cancer].
Vavra N; Nagele F; Rosen A; Klein M; Barrada M; Buxbaum P; Sevelda P
Geburtshilfe Frauenheilkd; 1994 Jul; 54(7):397-400. PubMed ID: 7926571
[TBL] [Abstract][Full Text] [Related]
38. Colposcopy of adenocarcinoma in situ and invasive adenocarcinoma of the cervix.
Lickrish GM; Colgan TJ; Wright VC
Obstet Gynecol Clin North Am; 1993 Mar; 20(1):111-22. PubMed ID: 8332305
[TBL] [Abstract][Full Text] [Related]
39. Invasive adenocarcinoma of the vagina following surgery for adenocarcinoma in situ of the cervix--recurrence or implantation?
Narayansingh GV; Cumming GP; Dighe S; Parkin DE; Millar I
Int J Gynecol Cancer; 2001; 11(6):493-5. PubMed ID: 11906556
[TBL] [Abstract][Full Text] [Related]
40. Conservative treatment of stage IA1 adenocarcinoma of the cervix during pregnancy.
Yahata T; Numata M; Kashima K; Sekine M; Fujita K; Yamamoto T; Tanaka K
Gynecol Oncol; 2008 Apr; 109(1):49-52. PubMed ID: 18289649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
